 Insulin use NIDDM Rationale pathophysiology disease basal hyperglycemia major feature non-insulin-dependent diabetes mellitus control fasting blood glucose concentration hierarchical sequence therapies major aim near-normal fasting blood glucose concentrations expectation development long-term complications diet tablet therapy effective fasting blood glucose level mM basal insulin supplement long-acting insulin ultralente blood glucose concentration little risk hypoglycemia patient normal life-style restrictions exercise size individual meals basal insulin supplement marked weight gain dose insulin level fasting blood glucose degree obesity index insulin resistance current evidence insulin therapy appropriate patients insulin deficiency insulin resistance benefit near-normal glucose concentrations putative risk hyperinsulinemia affected patients additional regular insulin meals blood glucose normal basal insulin supplement endogenous insulin production advantageous production islet amyloid polypeptide islet amyloid formation